Clearday, Inc. - Quarter Report: 2007 June (Form 10-Q)

SuperConductor Technologies Inc.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2007


o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-21074

SUPERCONDUCTOR TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)


Delaware		77-0158076
(State or other jurisdiction of		(IRS Employer
incorporation or organization)		Identification No.)

460 Ward Drive,
Santa Barbara, California 93111-2356
(Address of principal executive offices & zip code)

(805) 690-4500
(Registrant’s telephone number including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer o Accelerated Filer o Non-Accelerated Filer þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o or No þ

The registrant had 12,483,367 shares of the common stock outstanding as of the close of business on July 31, 2007.

SUPERCONDUCTOR TECHNOLOGIES INC.

INDEX TO FORM 10-Q

Three Months Ended June 30, 2007


SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS			1
WHERE YOU CAN FIND MORE INFORMATION			1
PART I — FINANCIAL INFORMATION
ITEM 1. Financial Statements
Condensed Consolidated Statement of Operations			2
Condensed Consolidated Balance Sheets			3
Condensed Consolidated Statement of Cash Flows			4
Notes to Unaudited Interim Condensed Consolidated Financial Statements.			5
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			15
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk			21
ITEM 4. Disclosure Controls and Procedures			21

PART II — OTHER INFORMATION
ITEM 1. Legal Proceedings			22
ITEM 1A. Risk Factors			22
ITEM 2. Unregistered Sales of Equity Securities			22
ITEM 4. Submission of Matters to a Vote of Security Holders			22
ITEM 5. Other Information			22
ITEM 6. Exhibits			22
SIGNATURE			23
EXHIBIT 31.1
EXHIBIT 31.2
EXHIBIT 32.1
EXHIBIT 32.2

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can find many (but not all) of these statements by looking for words such as “approximates,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans” “would,” “may” or other similar expressions in this Report. Our forward-looking statements relate to future events or our future performance and include, but are not limited to, statements concerning our business strategy, future commercial revenues, market growth, capital requirements, new product introductions, expansion plans and the adequacy of our funding. Other statements contained in this report that are not historical facts are also forward-looking statements.

We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995. We caution investors that any forward-looking statements presented in this Report, or which we may make orally or in writing from time to time, are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results can be expected to differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on past forward-looking statements, which are based on known results and trends at the time they are made, to anticipate future results or trends.

Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following: limited assets and a history of losses; needs for additional capital; limited number of potential customers; limited number of suppliers for some of our components; no significant backlog from quarter to quarter; significant fluctuations in product demand from quarter to quarter; and rapidly advancing technology. For further discussion of these and other factors see Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Part II, Item 1A.” Risk Factors” in this Report and in our 2006 Annual Report on Form 10-K.

This Report and all subsequent written and oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We do not undertake any obligation to release publicly any revisions to our forward-looking statements to reflect events or circumstances after the date of this Report.

WHERE YOU CAN FIND MORE INFORMATION

As a public company, we are required to file annually, quarterly and special reports, proxy statements and other information with the SEC. You may read and copy any of our materials on file with the SEC at the SEC’s Public Reference Room at 450 Fifth Street, N.W., Judiciary Plaza, Washington, DC 20549, as well as at the SEC’s regional office at 5757 Wilshire Boulevard, Suite 500, Los Angeles, California 90036. Our filings are available to the public over the Internet at the SEC’s website at http://www.sec.gov. Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room. We also provide copies of our Forms 8-K, 10-K, 10-Q, Proxy and Annual Report at no charge to investors upon request and make electronic copies of our most recently filed reports available through our website at www.suptech.com as soon as reasonably practicable after filing such material with the SEC.

PART I

FINANCIAL INFORMATION

Item 1. Financial Statements.

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(Unaudited)


	Three Months Ended						Six Months Ended
	July 1, 2006			June 30, 2007			July 1, 2006			June 30, 2007
Net revenues:
Net commercial product revenues	$	3,932,000		$	3,653,000		$	8,422,000		$	7,187,000
Government and other contract revenues		1,088,000			1,032,000			1,430,000			1,681,000
Sub license royalties		1,000			—			9,000			—


Total net revenues		5,021,000			4,685,000			9,861,000			8,868,000

Costs and expenses:
Cost of commercial product revenues		3,658,000			3,228,000			7,516,000			7,130,000
Contract research and development		703,000			607,000			1,007,000			1,055,000
Other research and development		630,000			813,000			1,931,000			1,725,000
Selling, general and administrative		2,678,000			2,043,000			5,395,000			3,941,000
Goodwill impairment charge		20,107,000			—			20,107,000			—


Total costs and expenses		27,776,000			6,691,000			35,956,000			13,851,000


Loss from operations		(22,755,000	)		(2,006,000	)		(26,095,000	)		(4,983,000	)
Interest income		107,000			35,000			234,000			86,000
Interest expense		(11,000	)		(11,000	)		(24,000	)		(22,000	)


Net loss	$	(22,659,000	)	$	(1,982,000	)	$	(25,885,000	)	$	(4,919,000	)


Basic and diluted loss per common share	$	(1.82	)	$	(0.16	)	$	(2.07	)	$	(0.39	)


Weighted average number of common shares outstanding		12,483,367			12,483,367			12,483,367			12,483,367

See accompanying notes to the unaudited interim condensed consolidated financial statements

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED BALANCE SHEETS


	December 31,			June 30,
	2006			2007
	(See Note)			(Unaudited)
ASSETS
Current Assets:
Cash and cash equivalents	$	5,487,000		$	2,912,000
Accounts receivable, net		1,535,000			2,201,000
Inventory, net		5,978,000			3,884,000
Prepaid expenses and other current assets		507,000			485,000

Total Current Assets		13,507,000			9,482,000

Property and equipment, net of accumulated depreciation of $18,599,000 and $19,598,000, respectively		5,770,000			4,795,000
Patents, licenses and purchased technology, net of accumulated amortization of $1,391,000 and $1,556,000, respectively		2,405,000			2,313,000
Other assets		222,000			209,000

Total Assets	$	21,904,000		$	16,799,000


LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	1,725,000		$	1,671,000
Accrued expenses		1,610,000			1,284,000
Current portion of capitalized lease obligations and long term debt		14,000			15,000

Total Current Liabilities		3,349,000			2,970,000

Other long term liabilities		604,000			594,000

Total Liabilities		3,953,000			3,564,000

Commitments and contingencies-Notes 8 and 9

Stockholders’ Equity:
Preferred stock, $.001 par value, 2,000,000 shares authorized, none issued and outstanding		—			—
Common stock, $.001 par value, 250,000,000 shares authorized, 12,483,367 shares issued and outstanding		12,000			12,000
Capital in excess of par value		208,825,000			209,001,000
Notes receivable from stockholder net		(27,000	)		—
Accumulated deficit		(190,859,000	)		(195,778,000	)

Total Stockholders’ Equity		17,951,000			13,235,000


Total Liabilities and Stockholders’ Equity	$	21,904,000		$	16,799,000

See accompanying notes to the unaudited interim condensed consolidated financial statements

Note-December 31, 2006 balances were derived from audited financial statements

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)


	Six Months Ended
	July 1, 2006			June 30, 2007
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(25,885,000	)	$	(4,919,000	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		1,365,000			1,212,000
Non-cash impairment charge		20,107,000			—
Warrants-Options		101,000			176,000
Provision for excess and obsolete inventories		180,000			160,000
Reserve for impairment of note and interest receivable from Stockholder		34,000			(583,000	)
Changes in assets and liabilities:
Accounts receivable		1,076,000			(666,000	)
Inventory		(2,345,000	)		1,934,000
Prepaid expenses and other current assets		213,000			676,000
Patents, licenses and purchased technology		(101,000	)		(92,000	)
Other assets		100,000			(13,000	)
Accounts payable, accrued expenses and other long- term liabilities		(589,000	)		(379,000	)

Net cash used in operating activities		(5,744,000	)		(2,494,000	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from the sale of property and equipment		—			25,000
Purchases of property and equipment		(170,000	)		(96,000	)

Net cash used in investing activities		(170,000	)		(71,000	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on long-term obligations		(9,000	)		(10,000	)

Net cash used in financing activities		(9,000	)		(10,000	)


Net decrease in cash and cash equivalents		(5,923,000	)		(2,575,000	)
Cash and cash equivalents at beginning of period		13,018,000			5,487,000

Cash and cash equivalents at end of period	$	7,095,000		$	2,912,000

See accompanying notes to the unaudited interim condensed consolidated financial statements.

SUPERCONDUCTOR TECHNOLOGIES INC.

NOTES TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

UNAUDITED

1. General

Superconductor Technologies Inc. was incorporated in Delaware on May 11, 1987 and maintains its headquarters in Santa Barbara, California. We operate in a single industry segment, the research, development, manufacture and marketing of high-performance infrastructure products for wireless voice and data applications. Our commercial products are divided into three product offerings: SuperLink (high-temperature superconducting filters), AmpLink (high performance, ground-mounted amplifiers) and SuperPlex (high performance multiplexers). Our research and development contracts are used as a source of funds for our commercial technology development. From 1987 to 1997, we were engaged primarily in research and development and generated revenues primarily from government research contracts.

We continue to be involved as either contractor or subcontractor on a number of contracts with the United States government. These contracts have been and continue to provide us a significant source of revenues. For the six months ended June 30, 2007 and July 1, 2006, government related contracts account for 19% and 15%, respectively, of our net revenues.

The unaudited consolidated financial information furnished herein has been prepared in accordance with generally accepted accounting principles and reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary for a fair statement of the results of operations for the periods presented.

The preparation of financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates and such differences may be material to the financial statements. This quarterly report on Form 10-Q should be read in conjunction with our Form 10-K for the year ended December 31, 2006. The results of operations for the three and six months ended June 30, 2007 are not necessarily indicative of results for the entire fiscal year ending December 31, 2007.

2. Summary of Significant Accounting Policies

Basis of Presentation

In the first six months of 2007, we incurred a net loss of $4.9 million and negative cash flows from operations of $2.5 million. In 2006, we incurred a net loss of $29.6 million and negative cash flows from operations of $7.3 million.

Our principal sources of liquidity consist of existing cash balances and funds expected to be generated from future operations. Based on our current forecasts, our cash resources may not be sufficient to fund our planned operations for the remainder of 2007. We believe one of the key factors to our liquidity in 2007 will be our ability to successfully execute on our plans to increase sales levels in a highly concentrated industry where we experience significant fluctuations in sales from quarter to quarter. Our cash requirements will also depend on numerous other variable factors, including the rate of growth of sales, the timing and levels of products purchased, payment terms and credit limits from manufacturers, and the timing and level of accounts receivable collections. As a result of the uncertainty of these many factors, we cannot give assurances that we will be able to continue operations in the absence of raising additional capital. Accordingly, we intend to raise funds in the next few months to continue operations in the absence of an improvement in our sales.

We cannot assure you that additional financing (public or private) will be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If we cannot raise any needed funds, we might be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and our viability as a company.

Our financial statements have been prepared assuming that we will continue as a going concern. The factors described above raise substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments that might result from this uncertainty.

Principles of Consolidation

The interim condensed consolidated financial statements include the accounts of Superconductor Technologies Inc. and our wholly owned subsidiaries. All significant intercompany transactions have been eliminated from the consolidated financial statements.

Cash and Cash Equivalents

Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less. Cash and cash equivalents are maintained with quality financial institutions and from time to time exceed FDIC limits.

Accounts Receivable

We sell predominantly to entities in the wireless communications industry and to entities of the United States Government. We grant uncollateralized credit to our customers. We perform ongoing credit evaluations of our customers before granting credit. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on historical write-off experience. Past due balances are reviewed for collectibility. Accounts balances are charged off against the allowance when we deem it is probable the receivable will not be recovered. We do not have any off balance sheet credit exposure related to our customers.

Revenue Recognition

Commercial revenues are principally derived from the sale of our SuperLink, AmpLink, and SuperPlex products and are recognized once all of the following conditions have been met: a) an authorized purchase order has been received in writing, b) customer‘s credit worthiness has been established, c) shipment of the product has occurred, d) title has transferred, and e) if stipulated by the contract, customer acceptance has occurred and all significant vendor obligations, if any, have been satisfied.

Contract revenues are principally generated under research and development contracts. Contract revenues are recognized utilizing the percentage-of-completion method measured by the relationship of costs incurred to total estimated contract costs. If the current contract estimate were to indicate a loss, utilizing the funded amount of the contract, a provision would be made for the total anticipated loss. Revenues from research related activities are derived primarily from contracts with agencies of the United States Government. Credit risk related to accounts receivable arising from such contracts is considered minimal. These contracts include cost-plus, fixed price and cost sharing arrangements and are generally short-term in nature.

All payments to us for work performed on contracts with agencies of the U.S. Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Based on historical experience and review of current projects in process, we believe that the audits will not have a significant effect on our financial position, results of operations or cash flows. The Defense Contract Audit Agency has completed audits of us through 2003.

Warranties

We offer warranties generally ranging from one to five years, depending on the product and negotiated terms of purchase agreements with our customers. Such warranties may require us to repair or replace defective product returned to us during such warranty period at no cost to the customer. An estimate by us for warranty related costs is recorded by us at the time of sale based on our actual historical product return rates and expected repair costs. Such costs have been within our expectations. See “Use of Estimates” in this note.

Guarantees

In connection with the sales and manufacturing of our commercial products, we indemnify, without limit or term, our customers and contract manufacturers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our guarantees because of the uncertainty as to whether a claim might arise and how much it might total. Historically, we have not incurred any expenses related to these guarantees.

Research and Development Costs

Research and development costs are expensed as incurred and include salary, facility, depreciation and material expenses. Research and development costs incurred solely in connection with research and development contracts are charged to contract

research and development expense. Other research and development costs are charged to other research and development expense.

Inventories

Inventories are stated at the lower of cost or market, with costs primarily determined using standard costs, which approximate actual costs utilizing the first-in, first-out method. Provision for potentially obsolete or slow moving inventory is made based on our analysis of inventory levels and sales forecasts. Costs associated with idle capacity are expensed immediately.

Property and Equipment

Property and equipment are recorded at cost. Equipment is depreciated using the straight-line method over their estimated useful lives ranging from three to five years. Leasehold improvements and assets financed under capital leases are amortized over the shorter of their useful lives or the lease term. Furniture and fixtures are depreciated over seven years. Expenditures for additions and major improvements are capitalized. Expenditures for minor tooling, repairs and maintenance and minor improvements are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded in selling, general and administration expenses.

Patents, Licenses and Purchased Technology

Patents and licenses are recorded at cost and are amortized using the straight-line method over the shorter of their estimated useful lives or approximately seventeen years. Purchased technology acquired through the acquisition of Conductus, Inc. is recorded at our estimated fair value and is amortized using the straight-line method over seven years.

Long-Lived Assets

The realizability of long-lived assets is evaluated periodically as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in business are written off in the period identified since they will no longer generate any positive cash flows for us. Periodically, long-lived assets that will continue to be used by us need to be evaluated for recoverability. Such evaluation is based on various analyses, including cash flow and profitability projections. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets will be written down to their estimated fair value. We completed such an analysis the fourth quarter of 2006 and determined that no write down was necessary.

Loss Contingencies

In the normal course of business, we are subject to claims and litigation, including allegations of patent infringement. Liabilities relating to these claims are recorded when it is determined that a loss is probable and the amount of the loss can be reasonably estimated. The costs of defense in such matters are expensed as incurred. Insurance proceeds recoverable are recorded when deemed probable.

Income Taxes

In July 2006, the FASB issued Interpretation (“FIN”) No. 48, Accounting for Uncertainty in Income Taxes — An Interpretation of FASB Statement No. 109 (“FIN 48”). FIN 48 provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise’s financial statements in accordance with SFAS 109. Income tax positions must meet a more-likely-than-not recognition threshold at the effective date to be recognized upon the adoption of FIN 48 and in subsequent periods. We adopted FIN 48 effective January 1, 2007, and the provisions of FIN 48 have been applied to all income tax positions commencing from that date. There was no material impact from this adoption. As of December 31, 2006, we had net operating loss carryforwards for federal and state income tax purposes of approximately $275.1 million and $143.4 million, respectively. Due to the uncertainty surrounding their realization, we recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying balance sheet.

Marketing Costs

All costs related to marketing and advertising our products are expensed as incurred or at the time the advertising takes place. Advertising costs were not material in each of the three and six month periods ended June 30, 2007 and July 1, 2006.

Net Loss Per Share

Basic and diluted net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding in each period. Potentially dilutive shares are not included in the calculation of diluted loss per share because their effect is anti-dilutive.

Stock-based Compensation

Effective January 1, 2006, we adopted the provisions of Statement of Financial Accounting Standards (“SFAS”) No. 123(revised 2004), “Share-Based Payment” (“SFAS No. 123(R)”).

For the three and six months ended June 30, 2007 and July 1, 2006 the weighted average fair value has been estimated at the date of the grant using the Black-Scholes option-pricing model. The following are the significant weighted average assumptions used for estimating the fair value under our stock option plans:


	Three months ended						Six months ended
	July 1, 2006			June 30, 2007			July 1, 2006			June 30, 2007
Expected life in years		4.0			4.0			4.0			4.0
Risk free interest rate		4.85	%		4.95	%		4.82	%		4.80	%
Expected volatility		95	%		95	%		95	%		95	%
Dividend yield		0	%		0	%		0	%		0	%

The expected life was based on the contractual term of the options and the expected employee exercise behavior. Typically, options to our employees have a 4 year vesting term and a 10 year contractual term. The risk-free interest rate is based on the U. S. Treasury zero-coupon issues with a remaining term equal to the expected option life assumed at the grant date. The future volatility is based on our 4 year historical volatility. We used an expected dividend yield of 0% because we has never paid a dividend and do not anticipate paying dividends. We assumed a 10% forfeiture rate based on historical stock option cancellation rates over the last 4 years.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The significant estimates in the preparation of the financial statements relate to the assessment of the carrying amount of accounts receivable, inventory, intangibles, goodwill, estimated provisions for warranty costs, accruals for restructuring and lease abandonment costs, income taxes and litigation. Actual results could differ from those estimates and such differences may be material to the financial statements. For the quarter and year to date, we reversed a $319,000 product line exit cost accrual. This accrual was established in 2002 in the amount of $1,042,000 and represented the estimated costs to be incurred with a customer to support commercial product units previously purchased from Conductus for a period of five years.

Fair Value of Financial Instruments

The carrying amount of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to the short-term nature of these instruments. We estimate that the carrying amount of the debt approximates fair value based on our current incremental borrowing rates for similar types of borrowing arrangements.

Comprehensive Income (Loss)

We have no items of other comprehensive income (loss) in any period other than our net loss.

Segment Information

We operate in a single business segment, the research, development, manufacture and marketing of high performance products used in cellular base stations to maximize the performance of wireless telecommunications networks by improving the quality of uplink signals from mobile wireless devices. Net commercial product revenues are primarily derived from the sales of our SuperLink, AmpLink and SuperPlex products. We currently sell most of our product directly to wireless network

operators in the United States. Net revenues derived principally from government research and development contracts are presented separately on the statement of operations for all periods presented.

Certain Risks and Uncertainties

We have continued to incur operating losses. Our long-term prospects and execution of our business plan are dependent upon the continued and increased market acceptance for our products.

We currently sell most of our products directly to wireless network operators in the United States and our product sales have historically been concentrated in a small number of customers. In 2006, we had three customers that represented 44%, 20% and 16% of total net revenues. At December 31, 2006, these three customers represented 66% of accounts receivable. In the six months ended June 30, 2007, we had two customers that represented 49% and 12% of total net revenues. At June 30, 2007, these two customers represented 44% of accounts receivable. The loss of or reduction in sales, or the inability to collect outstanding accounts receivable, from any of these customers could have a material adverse effect on our business, financial condition, results of operations and cash flows.

We currently rely on a limited number of suppliers for key components of our products. The loss of any of these suppliers could have a material adverse effect on our business, financial condition, results of operations and cash flows.

In connection with the sales of our commercial products, we indemnify, without limit or term, our customers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our indemnity because of the uncertainty as to whether a claim might arise and how much it might total.

Recent Accounting Pronouncements

In September 2006, the Financial Accounting Standards Board (“FASB”) issued Statement No. 157, “Fair Value Measurements” (“SFAS 157”), which defines fair value, establishes a framework for using fair value to measure assets and liabilities, and expands disclosures about fair value measurements. The Statement applies whenever other statements require or permit assets or liabilities to be measured at fair value. SFAS 157 is effective for fiscal years beginning after November 15, 2007. We are currently evaluating the impact this Statement will have on our consolidated financial statements.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities Including an Amendment of FASB Statement No. 115” (“SFAS 159”). SFAS 159 permits entities to choose to measure many financial instruments and certain other items at fair value, with unrealized gains and losses related to these financial instruments reported in earnings at each subsequent reporting date. SFAS 159 is effective for fiscal years beginning after November 15, 2007. We are currently evaluating the impact this Statement will have on our consolidated financial statements.

3. Short Term Borrowings

We have a line of credit with a bank. The line of credit was renewed in July 2007 for a term of one year. The line of credit expires July 15, 2008 and is structured as a sale of accounts receivable. The agreement provides for the sale of up to $5 million of eligible accounts receivable, with advances to us totaling 80% of the receivables sold. Advances under the agreement are collateralized by all our assets. Under the terms of the agreement, we continue to service the sold receivables and are subject to recourse provisions. Advances bear interest at the prime rate (8.25% at June 30, 2007) plus 2.50% subject to a minimum monthly charge. There was no amount outstanding under this borrowing facility at June 30, 2007.

The agreement contains representations and warranties, affirmative and negative covenants and events of default customary for financings of this type. The failure to comply with these provisions, or the occurrence of any one of the events of default, would prevent any further borrowings and would generally require the repayment of any outstanding borrowings. Such representations, warranties and events of default include (a) non-payment of debt and interest hereunder, (b) non-compliance with terms of the agreement covenants, (c) insolvency or bankruptcy, (d) material adverse change, (e) merger or consolidation where our shareholders do not hold a majority of the voting rights of the surviving entity, (f) transactions outside the normal course of business, or (g) payment of dividends.

4. Notes Receivable From Stockholder

Prior to our acquisition of Conductus, Inc. in December 2002, a former director and stockholder executed two notes aggregating $820,244 in principal in connection with the exercise in December 2000 of two options to purchase Conductus,

Inc. common stock. Through the third quarter of 2005, we carried both notes as assets on our balance sheet. In the fourth quarter of 2005, we filed a lawsuit to collect both notes and recorded a reserve for the value of the notes (principal plus accrued interest) in excess of the market value of the collateral securing the notes. On March 2, 2007, we entered into a Settlement Agreement and Mutual Release of All Claims to settle the lawsuit, under which we received $610,000 in April 2007 and rescinded the second purported option exercise including cancellation of the related note.

5. Stockholders’ Equity

Stock Options

We currently have one active stock option plan, the 2003 Equity Incentive Plan. Under the 2003 Equity Incentive Plan, stock awards may consist of stock options, stock appreciation rights, restricted stock awards, performance awards, and performance share awards. Stock awards may be made to our key employees, consultants, and non-employee directors. Stock options granted under these plans must be granted at prices no less than 100% of the market value on the date of grant. Generally, stock options become exercisable in installments over a minimum of four years, beginning one year after the date of grant, and expire not more than ten years from the date of grant, with the exception of 10% or greater stockholders which may have options granted at prices no less than the market value on the date of grant, and expire not more than five years from the date of grant. We expect to issue new shares to cover stock option exercises and have no plans to repurchase shares. There were no stock option exercises in 2006 or in the six months ended June 30, 2007.

As a result of adopting SFAS 123R, the impact to the Consolidated Statement of Operations for the three months ended June 30, 2007 and July 1, 2006 was (i) $30,000 and $50,000 on net income and (ii) zero and zero on both basic and diluted earnings per share, respectively, and for the six months ended June 30, 2007 and July 1, 2006 was (ii) $64,000 and $101,000 on net income and (ii)$0.01 and $0.01 on both basic and diluted earnings per share, respectively. No stock compensation cost was capitalized during either period. The weighted-average fair value at the grant date for options issued in the first six months of 2007 was $1.30 per share versus $3.47 per share in the first six months of 2006. The total compensation cost related to non-vested awards not yet recognized is $158,000 and the weighted-average period over which the cost is expected to be recognized is 1.2 years in the first six months of 2007 versus $296,000 and 1.4 years in the first six months of 2006.

The following is a summary of stock option transactions under our stock option plans at June 30, 2007:


						Weighted				Weighted
						Average		Number of		Average
	Number of					Exercise		Options		Exercise
	Shares			Price Per Share		Price		Exercisable		Price
Balance at December 31, 2006		1,154,941		$	1.43 - $493.75	$	38.33		1,067,296	$	41.13
Granted		5,300		$	1.79 - $ 2.11	$	1.88
Exercised		—			—		—
Canceled		(32,583	)	$	8.00 - $295.00	$	37.80

Balance at June 30, 2007		1,127,658		$	1.43 - $493.75	$	38.13		1,063,808	$	40.19

The outstanding options expire by the end of January 2017. The weighted-average contractual term of options outstanding is 5.8 years and the weighted-average contractual term of stock options currently exercisable is slightly less than 5.8 years. The exercise prices for these options range from $1.43 to $493.75 per share, for an aggregate exercise price of approximately $43.0 million. At June 30, 2007 only 600 shares, with an intrinsic value of $36, of outstanding stock options had an exercise price less than the current market value. None of these were exercisable.

Restricted Stock Awards

In July 2006, we issued restricted stock awards for the first time. A total of 331,000 shares were granted and will fully vest in one single installment on the second anniversary of the grant date in July 2008. The per share weighted average grant-date fair value was $1.50. A 10% forfeiture rate was assumed.

The impact to the Consolidated Statement of Operations for the three and six months ended June 30, 2007 was an expense of $56,000 and $112,000 and zero and $0.01 on both basic and diluted earnings per share. No stock compensation cost was capitalized during the period. The total compensation cost related to non-vested awards not yet recognized is $242,000 and the weighted-average period over which the cost is expected to be recognized is 1.1 years.

Warrants

The following is a summary of outstanding warrants at June 30, 2007:


	Common Shares
	Total and		Price
	Currently		per
	Exercisable		Share		Expiration Date
Warrants related to issuance of common stock		140,658	$	11.90	December 17, 2007*
		116,279		29.00	June 24, 2008*
		342,466		11.10	August 16, 2010
Warrants related to April 2004 Bridge Loans		69,549		13.30	April 28, 2011* **
		10,000		18.50	April 28, 2011*
Warrants assumed in connection with the Conductus,		109,500		45.83	September 27, 2007
Inc. acquisition		600		312.50	September 1, 2007

Total		789,052


*		The terms of these warrants contain net exercise provisions, wherein instead of a cash exercise holders can elect to receive common stock equal to the difference between the exercise price and the average closing sale price for common shares over 10-30 days immediately preceding the exercise date.

**		These warrants contain anti-dilution adjustment provisions.

6. Legal Proceedings

Settlement of Litigation

We filed a lawsuit in the California Superior Court (Case No. 1186812) against a former director and stockholder in the fourth quarter of 2005 to collect amounts due under two notes aggregating $820,244 in principal. On March 2, 2007, we entered into a Settlement Agreement and Mutual Release of All Claims to settle the lawsuit, under which we received $610,000 in April 2007 and rescinded a second purported option exercise including cancellation of the related note.

7. Earnings Per Share

The computation of per share amounts for the three month periods ended July 1, 2006 and June 30, 2007 is based on the average number of common shares outstanding for the period. Options and warrants to purchase 2,000,679 and 1,916,710 shares of common stock during the three and six month periods ended July 1, 2006 and June 30, 2007, respectively, were not considered in the computation of diluted earnings per share because their inclusion would be anti-dilutive.

8. Commitments and Contingencies

Operating Leases

We lease our offices and production facilities under non-cancelable operating leases that expire at various times over the next six years. Generally, these leases contain escalation clauses for increases in annual renewal options and require us to pay utilities, insurance, taxes and other operating expenses.

Rent expenses totaled $273,000 and $548,000 for the three and six month periods ended June 30, 2007, and $282,000 and $573,000 for the three and six month periods ended July 1, 2006, respectively.

Capital Leases

We lease certain property and equipment under a capital lease arrangement that expires in August 2007. The lease bears interest at 14.95%.

Patents and Licenses

We have entered into various licensing agreements requiring royalty payments ranging from 0.13% to 2.5% of specified product sales. Certain of these agreements contain provisions for the payment of guaranteed or minimum royalty amounts. In the event that we fail to pay minimum annual royalties, these licenses may automatically become non-exclusive or be terminated. These royalty obligations terminate in 2009 to 2020. For the three and six months ended June 30, 2007, royalty

expense totaled $33,000 and $87,000, respectively. For the three and six months ended July 1, 2006, royalty expense totaled $38,000 and $77,000, respectively. Under the terms of certain royalty agreements, royalty payments made may be subject to audit. There have been no audits to date and we do not expect any possible future audit adjustments to be significant.

The minimum lease payments under operating and capital leases and license obligations are as follows:


			Operating
Year ending December 31,	Licenses		Leases		Capital Leases
Remainder of 2007	$	150,000	$	633,000	$	4,000
2008		150,000		1,304,000		—
2009		150,000		1,349,000		—
2010		150,000		1,396,000		—

2011		150,000		1,313,000		—

Thereafter		1,200,000		—		—


Total payments	$	1,950,000	$	5,995,000	$	4,000


Less: amount representing interest						—


Present value of minimum lease						4,000

Less current portion						(4,000	)


Long term portion					$	—

9. Contractual Guarantees and Indemnities

During our normal course of business, we make certain contractual guarantees and indemnities pursuant to which we may be required to make future payments under specific circumstances. We have not recorded any liability for these contractual guarantees and indemnities in the accompanying consolidated financial statements.

Warranties

We establish reserves for future product warranty costs that are expected to be incurred pursuant to specific warranty provisions with our customers. Our warranty reserves are established at the time of sale and updated throughout the warranty period based upon numerous factors including historical warranty return rates and expenses over various warranty periods.

Intellectual Property Indemnities

We indemnify certain customers and our contract manufacturers against liability arising from third-party claims of intellectual property rights infringement related to our products. These indemnities appear in development and supply agreements with our customers as well as manufacturing service agreements with our contract manufacturers, are not limited in amount or duration and generally survive the expiration of the contract. Given that the amount of any potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, we are unable to determine the maximum amount of losses that it could incur related to such indemnifications.

Director and Officer Indemnities and Contractual Guarantees

We have entered into indemnification agreements with our directors and executive officers which require us to indemnify such individuals to the fullest extent permitted by Delaware law. Our indemnification obligations under such agreements are not limited in amount or duration. Certain costs incurred in connection with such indemnifications may be recovered under certain circumstances under various insurance policies. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed against a director or executive officer, we are unable to determine the maximum amount of losses that we could incur relating to such indemnifications. Historically, any amounts payable pursuant to such director and officer indemnifications have not had a material negative effect on our business, financial condition or results of operations.

We have also entered into severance and change in control agreements with certain of our executives. These agreements provide for the payment of specific compensation benefits to such executives upon the termination of their employment with us.

General Contractual Indemnities/Products Liability

Short Term Borrowings

Advances under our line of credit with the bank are collateralized by all our assets. Under the terms of the agreement, we continue to service the sold receivables and are subject to recourse provisions. Under the terms of the agreement, if the bank determines that there is a material adverse change in our business, they can exercise all their rights and remedies under the agreement. There was no amount outstanding under this facility at June 30, 2007.

Contractual Contingency

We have a contract to deliver several custom products to a government contractor. We are unable to manufacture the products for technical reasons. We have discussed the problem with the contractor and our government customer. They are considering the problem, and further discussions are expected. We do not believe that a loss, if any, is reasonably estimable at this time and therefore has not recorded any liability relating to this matter. We will periodically reassess our potential liability as additional information becomes available. If we later determine that a loss is probable and the amount reasonably estimable, we will record a liability for the potential loss. All costs have been expensed and no revenues recognized on this contract.

10. Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities

Balance Sheet Data:


	December 31,			June 30,
	2006			2007
Accounts receivable:
Accounts receivable-trade	$	1,117,000		$	1,612,000
U.S. government accounts receivable-billed		493,000			664,000
Less: allowance for doubtful accounts		(75,000	)		(75,000	)

	$	1,535,000		$	2,201,000


	December 31,			June 30,
	2006			2007
Inventories:
Raw materials	$	2,368,000		$	1,863,000
Work-in-process		716,000			528,000
Finished goods		4,261,000			2,799,000
Less inventory reserve		(1,367,000	)		(1,306,000	)

	$	5,978,000		$	3,884,000


	December 31,			June 30,
	2006			2007
Property and Equipment:
Equipment	$	17,186,000		$	17,210,000
Leasehold improvements		6,732,000			6,732,000
Furniture and fixtures		451,000			451,000

		24,369,000			24,393,000
Less: accumulated depreciation and amortization		(18,599,000	)		(19,598,000	)

	$	5,770,000		$	4,795,000

At December 31, 2006 and June 30, 2007, equipment includes $237,000 of assets financed under capital lease arrangements, net of $223,000 and $233,000 of accumulated amortization, respectively. Depreciation expense amounted to $571,000 and $1,203,000 for the three and six month periods ended July 1, 2006 and $535,000 and $999,000 for the three and six month periods ended June 30, 2007, respectively.


	December 31,			June 30,
	2006			2007
Patents and Licenses:
Patents pending	$	628,000		$	630,000

Patents issued		899,000			970,000
Less accumulated amortization		(286,000	)		(315,000	)

Net patents issued		613,000			655,000

Licenses		563,000			563,000
Less accumulated amortization		(100,000	)		(117,000	)

Net licenses		463,000			446,000

Purchased technology		1,706,000			1,706,000
Less accumulated amortization		(1,005,000	)		(1,124,000	)

Net purchased technology		701,000			582,000

	$	2,405,000		$	2,313,000

Amortization expense related to these items totaled $81,000 and $162,000 for the three and six month periods ended July 1, 2006 and $81,000 and $165,000 for the three and six month periods ended June 30, 2007, respectively. Amortization expenses are expected to total $165,000 for the remainder of 2007, $350,000 in each of the years 2008 and 2009 and $119,000 in each of the years 2010 and 2011.


	December 31,			June 30,
	2006			2007
Accrued Expenses and Other Long Term Liabilities:
Salaries Payable	$	287,000		$	348,000
Compensated Absences		379,000			442,000
Compensation related		299,000			143,000
Warranty reserve		428,000			451,000
Lease abandonment costs		8,000			—
Product line exit costs		319,000			—
Deferred Rent		390,000			383,000
Other		104,000			128,000

		2,214,000			1,895,000
Less current portion		(1,610,000	)		(1,301,000	)

Long term portion	$	604,000		$	594,000


	For the six months ended,
	July 1,			June 30,
	2006			2007
Warranty Reserve Activity:
Beginning balance	$	491,000		$	428,000
Additions		68,000			51,000
Deductions		(170,000	)		(28,000	)

Ending balance	$	389,000		$	451,000


	For the six months ended,
	July 1,			June 30,
	2006			2007
Lease Abandonment Costs:
Beginning balance	$	225,000		$	8,000
Additions		—			—
Deductions		(217,000	)		(8,000	)

Ending balance	$	8,000			—


Product Line Exit Costs:
Beginning balance	$	402,000		$	319,000
Additions		—			—
Deductions		(83,000	)		(319,000	)

Ending balance	$	319,000			—


Severance Costs:
Beginning balance	$	32,000			—
Additions		81,000			—
Deductions		(113,000	)		—

Ending balance		—			—

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

General

We develop, manufacture and market high performance infrastructure products for wireless voice and data applications. Wireless carriers face many challenges in today’s competitive marketplace. Minutes of use are skyrocketing, and wireless users now expect the same quality of service from their mobile devices as from their landline phones. We help wireless carriers meet these challenges by “doing more with less.”

Our products help maximize the performance of wireless telecommunications networks by improving the quality of uplink signals from mobile wireless devices. Our products increase capacity utilization, lower dropped and blocked calls, extend coverage, and enable higher wireless data throughput — all while reducing capital and operating costs. SuperLink incorporates patented high-temperature superconductor (HTS) technology to create a receiver front-end that enhances network performance. Today, we are leveraging our expertise and proprietary technology in radio frequency (RF) engineering to expand our product line beyond HTS technology. We believe our RF engineering expertise provides us with a significant competitive advantage in the development of high performance, cost-effective solutions for the front end of wireless telecommunications networks.

We have three product offerings:

• SuperLink. In order to receive uplink signals from wireless handsets, base stations require a wireless filter system to eliminate, or filter out, out-of-band interference. SuperLink combines HTS filters with a proprietary cryogenic cooler and a cooled low-noise amplifier. The result is a highly compact and reliable receiver front-end that can simultaneously deliver both high selectivity (interference rejection) and high sensitivity (detection of low level signals). SuperLink delivers significant performance advantages over conventional filter systems.

• AmpLink. AmpLink is designed specifically to address the sensitivity requirements of wireless base stations. AmpLink is a ground-mounted unit which includes a high-performance amplifier and up to six dual duplexers. The enhanced uplink provided by AmpLink improves network coverage immediately and avoids the installation and maintenance costs associated with tower mounted alternatives.

• SuperPlex. SuperPlex is our line of multiplexers that provides extremely low insertion loss and excellent cross-band isolation. SuperPlex high-performance multiplexers are designed to eliminate the need for additional base station antennas and reduce infrastructure costs. Relative to competing technologies, these products offer increased transmit power delivered to the base station antenna, higher sensitivity to subscriber handset signals, and fast and cost-effective network overlays.

We currently sell most of our commercial products directly to wireless network operators in the United States. Our primary customers to date include ALLTEL, Cingular, Sprint Nextel, T-Mobile, U.S. Cellular and Verizon Wireless. We

have a concentrated customer base. Verizon Wireless and Cingular each accounted for more than 10% of our commercial revenues in 2007 and Verizon Wireless, ALLTEL and T-Mobile each accounted for more than 10% of our commercial revenues in 2006. We plan to expand our customer base by selling directly to other wireless network operators and manufacturers of base station equipment, but we cannot assure that this effort will be successful.

We also generate significant revenues from government contracts. We primarily pursue government research and development contracts which compliment our commercial product development. We undertake government contract work which has the potential to add to or improve our commercial product line. These contracts often yield valuable intellectual property relevant to our commercial business. We typically own the intellectual property developed under these contracts, and the Federal Government receives a royalty-free, non-exclusive and nontransferable license to use the intellectual property for the United States.

We sell most of our products to a small number of wireless carriers, and their demand for wireless communications equipment fluctuates dramatically and unpredictably. We expect these trends to continue and may cause significant fluctuations in our quarterly and annual revenues.

The wireless communications infrastructure equipment market is extremely competitive and is characterized by rapid technological change, new product development, product obsolescence, evolving industry standards and price erosion over the life of a product. We face constant pressures to reduce prices. Consequently, we expect the average selling prices of our products will continue decreasing over time. We have responded in the past by successfully reducing our product costs, and expect further cost reductions over the next twelve months. However, we cannot predict whether our costs will decline at a rate sufficient to keep pace with the competitive pricing pressures.

Recent Developments

Settlement of Litigation

On March 2, 2007, we entered into a Settlement Agreement and Mutual Release of All Claims with Mr. Shalvoy to settle a lawsuit under which we received $610,000 in April 2007 and rescinded Mr. Shalvoy’s second purported option exercise including cancellation of the related note. Accordingly, we reversed $610,000 in reserves in this first quarter of 2007, reducing our operating expenses by that amount.

U.S. Air Force Contract

On April 20, 2007, we entered into a $4.7 million contract with the U. S. Air Force to develop Semiconductor-Tuned High Temperature Superconducting Filters for Ultra-Sensitive Radio Frequency Receivers (SURF). During this initial twelve month contract, which provides for progress billings, the U.S. Air Force has an option to extend the contract for an additional $5.4 million to develop a prototype rack-mountable system.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to bad debts, inventories, recovery of long-lived assets, including intangible assets, income taxes, warranty obligations, and contingencies. We base our estimates on historical experience and on various other assumptions that we believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of the financial statements. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We write down our inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required.

Our inventory is valued at the lower of our actual cost or the current estimated market value of the inventory. We review inventory quantities on hand and on order and record a provision for excess and obsolete inventory and/or vendor cancellation charges related to purchase commitments. Such provisions are established based on historical usage, adjusted for known changes in demands for such products, or the estimated forecast of product demand and production requirements. Our business is characterized by rapid technological change, frequent new product development and rapid product obsolescence that could result in an increase in the amount of obsolete inventory quantities on hand. As demonstrated in the

past three years, demand for our products can fluctuate significantly. Our estimates of future product demand may prove to be inaccurate and we may understate or overstate the provision required for excess and obsolete inventory.

Our net sales consist of revenue from sales of products net of trade discounts and allowances. We recognize revenue when evidence of an arrangement exists, contractual obligations have been satisfied, title and risk of loss have been transferred to the customer and collection of the resulting receivable is reasonably assured. At the time revenue is recognized, we provide for the estimated cost of product warranties if allowed for under contractual arrangements. Our warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Should such failure rates or costs differ from these estimates, accrued warranty costs would be adjusted.

We periodically evaluate the realizability of long-lived assets as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in business are written off in the period identified since they will no longer generate any positive cash flows for us. Periodically, long-lived assets that will continue to be used by us need to be evaluated for recoverability. Such evaluation is based on various analyses, including cash flow and profitability projections. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets will be written down to their estimated fair value. We completed such an analysis during fiscal 2006 and determined that no write down was necessary. Our estimates of future cash flows may prove to be inaccurate, and we may understate or overstate the write down of long-lived assets. During the first half of 2007, our market capitalization declined. If our market capitalization declines below our book value, and it is deemed other than temporary, then an impairment loss relating to our long-lived assets might be recognized. Any future impairment of our long-lived assets could have a material adverse effect on our financial position and results of operations.

Our valuation allowance against the deferred tax assets is based on our assessments of historical losses and projected operating results in future periods. If and when we generate future taxable income in the U.S. against which these tax assets may be applied, some portion or all of the valuation allowance would be reversed and an increase in net income would consequently be reported in future years.

We have a contract to deliver several custom products to a government contractor. We are unable to manufacture the products for technical reasons. We have discussed the problem with the contractor and our government customer. They are considering the problem, and we expect further discussions. We do not believe that a loss is reasonably estimable at this time and therefore have not recorded any liability relating to this matter. We will periodically reassess our potential liability as additional information becomes available. If we later determine that a loss is probable and the amount reasonably estimable, we would record a liability for the potential loss.

We account for stock-based compensation in accordance with the provisions of SFAS 123R. We use the Black-Scholes option-pricing model, which requires the input of highly subjective assumptions. These assumptions include estimating the length of time an employee will retain their stock options before exercising them (“expected term”), the estimated volatility of our common stock price over the expected term and the number of options that will ultimately not complete their vesting requirements (“forfeitures”). Changes in the subjective assumptions can materially affect the estimated fair value of the stock-based compensation and consequently, the related amount recognized on the consolidated statements of operations. See Notes 2 and 6 of the Notes to Consolidated Financial Statements in this Form 10-Q for further discussion of stock-based compensation.

Backlog

Our commercial backlog consists of accepted product purchase orders with scheduled delivery dates during the next twelve months. We had commercial backlog of $143,000 at June 30, 2007, as compared to $75,000 at December 31, 2006.

Results of Operations

Quarter and six months ended June 30, 2007 as compared to the quarter and six months ended July 1,
2006

Total net revenues decreased by $336,000, or 7%, to $4.7 million in the second quarter of 2007 from $5.0 million in the second quarter of 2006. Total net revenues decreased by $993,000, or 10%, to $8.9 million in the first six months of 2007 from $9.9 million in the same period last year. Total net revenues consist primarily of commercial product revenues and government contract revenues. We also generate some additional revenues from sublicensing our technology.

Net commercial product revenues decreased to $3.6 million in the second quarter of 2007 from $3.9 million in the second quarter of 2006, a decrease of $279,000, or 7%. For the first six months of 2007, net commercial product revenues decreased $1.2 million to $7.2 million from $8.4 million in the same period last year, a decrease of 15%. The decrease is primarily the result of lower sales of our SuperPlex products. Our three largest customers accounted for 70% of our total net revenues in the first half of 2007. These customers generally purchase products through non-binding commitments with minimal lead-times. Consequently, our commercial product revenues can fluctuate dramatically from quarter to quarter based on changes in our customers’ capital spending patterns.

Government contract revenues decreased to $1,032,000 in the second quarter of 2007 from $1,088,000 in the second quarter of 2006, a decrease of $56,000, or 5%. For the first six months of 2007, government contract revenues increased to $1.6 million from $1.4 million in the same period last year, an increase of $251,000, or 18%. The variance is primarily attributable to the completion of contracts in 2006 that were not replaced until the second quarter of 2007.

Cost of commercial product revenues includes all direct costs, manufacturing overhead, provision for excess and obsolete inventories and restructuring and impairment charges relating to the manufacturing operations. The cost of commercial product revenue totaled $3.2 million for the second quarter of 2007 compared to $3.7 million for the second quarter of 2006, a decrease of $430,000, or 12%. For the first six months of 2007, the cost of commercial product revenues totaled $7.1 million as compared to $7.5 million for the first six months of 2006, a decrease of $386,000, or 5%. For the quarter and year to date, decreased costs resulted primarily from the reversal of a $319,000 product line exit cost accrual. This accrual was established in 2002 in the amount of $1,042,000 and represented the estimated costs to be incurred with a customer to support commercial product units previously purchased from Conductus for a period of five years.

Our cost of sales includes both variable and fixed cost components. The variable component consists primarily of materials, assembly and test labor, overhead, which includes equipment and facility depreciation, transportation costs and warranty costs. The fixed component includes test equipment and facility depreciation, purchasing and procurement expenses and quality assurance costs. Given the fixed nature of such costs, the absorption of our production overhead costs into inventory decreases and the amount of production overhead variances expensed to cost of sales increases as production volumes decline since we have fewer units to absorb our overhead costs against. Conversely, the absorption of our production overhead costs into inventory increases and the amount of production overhead variances expensed to cost of sales decreases as production volumes increase since we have more units to absorb our overhead costs against. As a result, our gross profit margins generally decrease as revenue and production volumes decline due to lower sales volume and higher amounts of production overhead variances expensed to cost of sales; and our gross profit margins generally increase as our revenue and production volumes increase due to higher sales volume and lower amounts of production overhead variances expensed to cost of sales.

The following is an analysis of our commercial product gross profit and margins:


	Three Months Ended								Six Months Ended
Dollars in thousands	July 1, 2006				June 30, 2007				July 1, 2006				June 30, 2007
Net commercial product sales	$	3,932	100	%	$	3,653	100	%	$	8,422	100	%	$	7,187	100	%
Cost of commercial product sales		3,658	93	%		3,228	88	%		7,516	89	%		7,130	99	%

Gross profit	$	274	7	%	$	425	12	%	$	906	11	%	$	57	1	%

We had a gross profit of $425,000 in the second quarter of 2007 from the sale of our commercial products as compared to a gross profit of $274,000 in the second quarter of 2006. For the six months ended June 30, 2007, we had a gross profit of $57,000 from the sale of our commercial products as compared to a gross profit of $906,000 in the six months ended July 1, 2006. Our gross margins were adversely impacted by lower sales volume as well as charges for excess and obsolete inventory of approximately $160,000 and $180,000 in the first six months of 2007 and 2006, respectively. We regularly review inventory quantities on hand and provide an allowance for excess and obsolete inventory based on numerous factors including sales backlog, historical inventory usage, forecasted product demand and production requirements for the next twelve months.

Contract research and development expenses totaled $607,000 in the second quarter of 2007 as compared to $703,000 in the second quarter of 2006. These expenses totaled $1,055,000 in the first half of 2007 and $1,007,000 in the first half of 2006. This increase was the result of higher expenses associated with performing our government contracts in the first quarter and two new contracts added in the second quarter.

Other research and development expenses relate to development of new wireless commercial products. We also incur design expenses associated with reducing the cost and improving the manufacturability of our existing products. These expenses totaled $813,000 in the second quarter of 2007 as compared to $630,000 in the same quarter of the prior year and totaled $1.7 million in the first half of 2007 and $1.9 million in the first half of 2006. The increase in the second quarter expenses was due to increased efforts to complete internal projects prior to award of new government contracts.

Selling, general and administrative expenses totaled $2.0 million in the second quarter of 2007, as compared to $2.7 million in the second quarter of the prior year. In the first six months of 2007, these expenses totaled $3.9 million as compared to $5.4 million in the same period last year. The lower expenses in 2007 resulted primarily from reversal of a $610,000 reserve (see “Settlement of Litigation” under Legal Proceedings Note to the Financial Statements), lower insurance premiums and lower selling costs.

Interest expense in the three months and six months ended June 30, 2007 amounted to $11,000 and $22,000, as compared to $11,000 and $24,000 in the three months and six months ended July 1, 2006.

We had a net loss of $2.0 million for the quarter ended June 30, 2007, as compared to a net loss of $22.7 million in the same period last year. For the six months ended June 30, 2007, our loss totaled $4.9 million as compared to a net loss of $25.9 million in the same period last year.

The net loss available to common shareholders totaled $0.16 per common share in the second quarter of 2007, as compared to a net loss of $1.82 per common share in the same period last year. The net loss available to common shareholders totaled $0.39 per common share in the first half of 2007, as compared to a net loss of $2.07 per common share in the same period last year.

Liquidity and Capital Resources

Cash Flow Analysis

As of June 30, 2007, we had working capital of $6.5 million, including $2.9 million in cash and cash equivalents, as compared to working capital of $10.2 million at December 31, 2006, which included $5.5 million in cash and cash equivalents. We currently invest our excess cash in short-term, investment-grade, money-market instruments with maturities of three months or less. We believe that all of our cash investments would be readily available to us should the need arise.

Cash and cash equivalents decreased by $2.6 million to $2.9 million at June 30, 2007 from $5.5 million at December 31, 2006. Cash during this period was used primarily in operations and to a lesser extent for the purchase of property and equipment and for the payment of long-term borrowings.

Cash used in operations totaled $2.5 million in the first half of 2007. We used $4 million to fund the cash portion of our net loss. We also used cash to fund a $1.0 million increase in accounts receivable and accounts payable payments. These uses were offset by cash generated from the sale of inventory, prepaid expenses and other assets totaling $2.5 million. Cash used in operations totaled $5.7 million in the first half of 2006. We used $4.1 million to fund the cash portion of our net loss. We also used cash to fund a $3.0 million increase in inventory, patents and licenses, other assets and accounts payable payments. These uses were partially offset by cash generated from the collection of accounts receivable, prepaid expenses and other assets totaling $1.4 million.

Net cash used in investing activities totaled $71,000 in the first half of 2007 as compared to $170,000 in the first half of last year. These expenditures related primarily to purchases of manufacturing equipment and facilities improvements to increase our production capacity. The first half 2007 investing activity is net of $25,000 in equipment sales.

Net cash used in financing activities totaled $10,000 in the first half of 2007 and was used to pay down our long term debt. Net cash used in financing activities totaled $9,000 in the first half of 2006, including cash used to pay down our line of credit and long term debt of $9,000.

Financing Activities

We have historically financed our operations through a combination of cash on hand, cash provided from operations, equipment lease financings, available borrowings under bank lines of credit and both private and public equity offerings. We have effective registration statements on file with the SEC covering the public resale by investors of all the common stock issued in our private placements, as well as any common stock acquired upon exercise of their warrants.

We have an existing line of credit from a bank. It is a material source of funds for our business. The line of credit was renewed in July 2007 for a term of one year. The line of credit expires July 15, 2008. The loan agreement is structured as a

sale of our accounts receivable and provides for the sale of up to $5.0 million of eligible accounts receivable, with advances to us totaling 80% of the receivables sold. Advances bear interest at the prime rate (8.25% at June 30, 2007) plus 2.50% per annum subject to a minimum monthly charge. There was no amount outstanding under this borrowing facility at June 30, 2007. Advances are collateralized by a lien on all of our assets. Under the terms of the agreement, we continue to service the sold receivables and are subject to recourse provisions.

Contractual Obligations and Commercial Commitments

We incur various contractual obligations and commercial commitments in our normal course of business. They consist of the following:

	•		Capital Lease Obligations. Our capital lease obligations are for property and equipment and total $4,000 at June 30, 2007.

	•		Operating Lease Obligations. Our operating lease obligations consist of a facility lease in Santa Barbara, California, several copier leases and a forklift lease.

	•		Patents and Licenses. We have entered into various licensing agreements requiring royalty payments ranging from 0.13% to 2.5% of specified product sales. Some of these agreements contain provisions for the payment of guaranteed or minimum royalty amounts. Typically, the licensor can terminate our license if we fail to pay minimum annual royalties.

	•		Purchase Commitments. In the normal course of business, we incur purchase obligations with vendors and suppliers for the purchase of inventory, as well as other goods and services. These obligations are generally evidenced by purchase orders that contain the terms and conditions associated with the purchase arrangements. We are committed to accept delivery of such material pursuant to the purchase orders subject to various contract provisions which allow us to delay receipt of such orders or cancel orders beyond certain agreed upon lead times. Cancellations may result in cancellation costs payable by us.

Capital Expenditures

We plan to invest less than $200,000 in fixed assets during the remainder of 2007.

Future Liquidity

Our independent registered public accounting firm has included in their audit report for fiscal 2006 an explanatory paragraph expressing doubt about our ability to continue as a going concern. Our prior firm included a similar explanatory paragraph in their audit report for 2004 and 2005. In the first half of 2007, we incurred a net loss of $4.9 million and had negative cash flows from operations of $2.5 million. In 2006, we incurred a net loss of $29.6 million and had negative cash flows from operations of $7.3 million

Our financial statements have been prepared assuming that we will continue as a going concern. The factors described above raise substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments that might result from this uncertainty.

Net Operating Loss Carryforward

As of December 31, 2006, we had net operating loss carryforwards for federal and state income tax purposes of approximately $275.1 million and $143.4 million, respectively, which expire in the years 2007 through 2026. Of these amounts $91.2 million and $23.5 million, respectively resulted from the acquisition of Conductus. Included in the net operating loss carryforwards are deductions related to stock options of approximately $24.1 million and $13.1 million for federal and

California income tax purposes, respectively. To the extent net operating loss carryforwards are recognized for accounting purposes the resulting benefits related to the stock options will be credited to stockholders’ equity. In addition, we have research and development and other tax credits for federal and state income tax purposes of approximately $2.4 million and $983,000, respectively, which expire in the years 2007 through 2026. Of these amounts $661,000 and $736,000, respectively resulted from the acquisition of Conductus.

Due to the uncertainty surrounding their realization, we have recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying balance sheet.

Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of net operating loss carryforwards based on a statutory rate of return (usually the “applicable federal funds rate”, as defined in the Internal Revenue Code) and the value of the corporation at the time of a “change of ownership” as defined by Section 382. We completed an analysis of our equity transactions and determined that we had a change in ownership in August 1999 and December 2002. Therefore, the ability to utilize net operating loss carryforwards incurred prior to the change of ownership totaling $98 million will be subject in future periods to an annual limitation of $1.3 million. In addition, we acquired the right to Conductus’ net operating losses, which are also subject to the limitations imposed by Section 382. Conductus underwent three ownership changes, which occurred in February 1999, February 2001 and December 2002. Therefore, the ability to utilize Conductus’ net operating loss carryforwards of $91.2 million incurred prior to the ownership changes will be subject in future periods to annual limitation of $700,000. Net operating losses incurred by us subsequent to the ownership changes totaled $86.4 million and are not subject to this limitation.

Recent Accounting Requirements

Forward-Looking Statements

Please read the section in our 2006 Annual Report on Form 10-K entitled Item 1A “Risk Factors” for a description of additional uncertainties and factors that may affect our forward-looking statements. Forward-looking statements are based on information presently available to our senior management, and we do not assume any duty to update our forward-looking statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There was no material change in our exposure to market risk at June 30, 2007 as compared with our market risk exposure on December 31, 2006. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Market Risk” in our 2006 Annual Report on Form 10-K.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit, is recorded, processed, summarized and reported, within the time periods specified in the U.S. Securities and Exchange Commission’s rules and forms, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosures..

Our Chief Executive Officer and Controller have evaluated our disclosure controls and procedures and have concluded, as of June 30, 2007, that they are effective as described above.

Changes in Internal Controls

There have been no changes in our internal control over financial reporting during the second quarter of 2006 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Because of our inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

PART II

OTHER INFORMATION

Item 1. Legal Proceedings.

Settlement of Litigation

We filed a lawsuit in the California Superior Court (Case No. 1186812) against Mr. Shalvoy, a former director and stockholder, in the fourth quarter of 2005 to collect amounts due under two notes aggregating $820,244 in principal in connection with the exercise in December 2000 of two options to purchase Conductus, Inc. common stock prior to our acquisition of Conductus, Inc. in December 2002. On March 2, 2007, we entered into a Settlement Agreement and Mutual Release of All Claims with Mr. Shalvoy to settle the lawsuit, under which we received $610,000 in April 2007 and rescinded Mr. Shalvoy’s second purported option exercise including cancellation of the related note.

Routine Litigation

We may be involved in routine litigation arising in the ordinary course of our business, and, while the results of the proceedings cannot be predicted with certainty, we believe that the final outcome of such matters will not have a material adverse effect on our financial position, operating results or cash flow.

Item 1A. Risk Factors.

A description of the risk factors associated with our business is contained in Item 1A, “Risk Factors,” of our 2006 Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 2, 2007. There are no material changes from the risk factors previously disclosed in our 2006 Annual Report on Form 10-K..

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

We did not conduct any offerings of equity securities during the second quarter of this year that were not registered under the Securities Act of 1933.

We did not repurchase any shares of our common stock during the second quarter of this year.

Item 4. Submission of Matters to a Vote of Security Holders.

We did not submit any matters to a vote of security holders during the second quarter of this year.

Item 5. Other Information.

(a) Additional Disclosures.

None.

(b) Stockholder Nominations.

There have been no material changes to the procedures by which stockholders may recommend nominees to our board of directors.

Item 6. Exhibits.


Number		Description of Document
31.1		Statement of CEO Pursuant to 302 of the Sarbanes-Oxley Act of 2002 (*)

31.2		Statement of Principal Financial Officer Pursuant to 302 of the Sarbanes-Oxley Act of 2002 (*)

32.1		Statement of CEO Pursuant to 906 of the Sarbanes-Oxley Act of 2002 (*)

32.2		Statement of Principal Financial Officer Pursuant to 906 of the Sarbanes-Oxley Act of 2002 (*)


*		Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SUPERCONDUCTOR TECHNOLOGIES INC.


Dated: August 09, 2007		/s/ William J. Buchanan

		William J. Buchanan
		Controller (Principal Financial Officer)

		/s/ Jeffrey A. Quiram

		Jeffrey A. Quiram
		President and Chief Executive Officer

Clearday, Inc. - Quarter Report: 2007 June (Form 10-Q)

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents